 GPT Infraprojects Ltd receives contract worth Rs. 37.8 crore
GPT Infraprojects Ltd receives contract worth Rs. 37.8 crore Dr Lal PathLabs Limited recommends 1:1 bonus issue
Dr Lal PathLabs Limited recommends 1:1 bonus issue RITES signs MoU with Shipping Corporation of India
RITES signs MoU with Shipping Corporation of India XTGlobal announces new client win for Circulus AP Automation Solution in the U.S. Construction Sector
XTGlobal announces new client win for Circulus AP Automation Solution in the U.S. Construction Sector Atishay Ltd empanelled as Business Associate with RailTel
Atishay Ltd empanelled as Business Associate with RailTel 
              The Board of Directors of Bal Pharma Ltd at its meeting held on August 11, 2014, has proposed to issue 13,00,000 securities, on preferential basis to certain strategic investors who have expressed their interest in investing in the Company, which is subject to the approval of the members at the ensuing Annual General Meeting of the Company.
Shares of BAL PHARMA LTD. was last trading in BSE at Rs.59.65 as compared to the previous close of Rs. 56.85. The total number of shares traded during the day was 22286 in over 114 trades.
The stock hit an intraday high of Rs. 59.65 and intraday low of 59.65. The net turnover during the day was Rs. 1329359.